Start with mild which is quicker and easier to assess response
- Forums
- ASX - By Stock
- Ann: Approval to Start Phase I/II Diabetic Foot Ulcer Study
RCE
recce pharmaceuticals ltd
Add to My Watchlist
0.00%
!
30.0¢

Start with mild which is quicker and easier to assess response
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.51M |
Open | High | Low | Value | Volume |
30.0¢ | 30.0¢ | 30.0¢ | $2.183K | 7.276K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 20795 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 11724 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 20795 | 0.295 |
4 | 46650 | 0.290 |
4 | 85000 | 0.285 |
13 | 350389 | 0.280 |
7 | 71421 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 11724 | 1 |
0.310 | 1325 | 2 |
0.315 | 795 | 1 |
0.325 | 16800 | 2 |
0.340 | 7996 | 1 |
Last trade - 11.50am 03/07/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online